When was Clear Labs founded?

Clear Labs was founded in 2014 and raised its 1st funding round within a year of its incorporation.

Where is Clear Labs located?

Clear Labs is headquartered in Menlo Park, United States. It is registered at San Carlos, California.

Who is the current CEO of Clear Labs?

Sasan Amini and Mahni Ghorashi s of Clear Labs. Sasan Amini has also founded 1 company.

How many employees does Clear Labs have?

As of Mar 31, 2026, the latest employee count at Clear Labs is 82.

Is Clear Labs a funded company?

Clear Labs is a funded company, having raised a total of $171M across 9 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 02, 2014.

When was the latest funding round of Clear Labs?

Clear Labs' latest funding was a $***** Series D round on Dec 12, 2024, with participation from 10 investors.

Where does Clear Labs rank among its competitors?

Clear Labs ranks 8th amongst 393 active competitors, of which 95 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was HaystackAnalytics, which secured $5M in Sep, 2025.

Who are the top competitors of Clear Labs?

Clear Labs' top competitors include Adaptive Biotechnologies, MeMed and HaystackAnalytics. Among them, HaystackAnalytics secured the most recent funding round in September, 2025.

Clear Labs - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of food safety technologies for the identification of pathogens. The company offers Clear Dx, a rapid, high throughput next-generation sequencing (NGS) platform for clinical and public health labs that offers a complete characterization of SARS-CoV-2.

Website: www.clearlabs.com/
Social
Registered Address: San Carlos, California

Key Metrics

Founded Year

2014

Location

Menlo Park, United States

Stage

Series D

Total Funding

$171M in 9 rounds

Latest Funding Round

Series D, Dec 12, 2024, $*****

Investors

Menlo Ventures & 27 more

Ranked

8^th among 393 active competitors

Employee Count

82 as on Mar 31, 2026

Similar Companies

Adaptive Biotechnologies & 484 more

View Clear Labs' full profile

Clear Labs is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Clear Labs, Inc. CIN: 463655012 , United States, Active	Dec 26, 999	-	55 (As on Dec 31, 2019)	-

Clear Labs has raised a total funding of $171M over 9 rounds. Its first funding round was on Jan 02, 2014. Its latest funding round was a Series D round on Dec 12, 2024 for $*****. 10 investors participated in its latest round. Clear Labs has 28 institutional investors.

Here is the list of recent funding rounds of Clear Labs:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 12, 2024	3285854	Series D	4556711	4089782	2196231	5141382
May 26, 2021	8993612	Series C	6993258	6581342	7998966	Redmile Group & 7 more
May 18, 2020	8308382	Series B	6274868	9303039	Google Ventures & 3 more	4279804

Access funding benchmarks and valuations. Sign up today!

View details of Clear Labs's funding rounds and investors

The founders of Clear Labs are Sasan Amini and Mahni Ghorashi. Sasan Amini is the CEO of Clear Labs.

Here are the details of Clear Labs' key team members:

Sasan Amini: Co-Founder & CEO of Clear Labs and founder of 1 other company.
Contact Info: 1 email address
Mahni Ghorashi: Co-Founder & CEO of Clear Labs.

View details of Clear Labs's Founder profiles and Board Members

Clear Labs' employee count trend

Clear Labs has 82 employees as of Mar 26. Here is Clear Labs's employee count trend over the years:

Uncover Clear Labs' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Clear Labs include Adaptive Biotechnologies, MeMed and HaystackAnalytics. Here is the list of Top 10 competitors of Clear Labs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Adaptive Biotechnologies 2009, Seattle (United States), Public	Provider of clinical diagnostics, and drug discovery for immune diseases	$419M	Viking Global Investors, Matrix & 21 others	72/100
2nd	MeMed 2009, Tirat Carmel (Israel), Series D	Provider of machine learning based diagnostic solutions for infectious diseases	$163M	La Maison Partners, Ping An & 23 others	69/100
3rd	HaystackAnalytics 2018, Mumbai (India), Seed	Provider of genomics technology for personalized clinical decisions	$17.3M	SINE, Sun Pharma & 31 others	66/100
4th	OpGen 2002, Rockville (United States), Public	Developer of diagnostics and bioinformatics platforms for providers	$77.5M	Cross Creek, 180 Degree Capital & 12 others	66/100
5th	Inflammatix 2016, San Francisco (United States), Series E	Provider of diagnostic solutions for systemic infections	$191M	Khosla Ventures, Think.Health & 16 others	64/100
6th	Day Zero Diagnostics 2016, Boston (United States), Series B	Developer of genome sequencing-based diagnostics for infectious diseases	$49M	Triventures, Sands Capital & 10 others	64/100
7th	Karius 2014, Redwood City (United States), Series C	Provider of diagnostics for identifying infectious diseases using microbial DNA	$315M	Khosla Ventures, Tencent & 16 others	58/100
8th	Clear Labs 2014, Menlo Park (United States), Series D	Provider of food safety technologies for the identification of pathogens	$171M	Redmile Group, Tencent & 26 others	57/100
9th	PathoQuest 2010, Paris (France), Acquired	Provider of next-generation sequencing for microbiology testing	$9.99M	Kurma Partners, SHS & 8 others	57/100
10th	Seegene Technologies 2000, Seoul (South Korea), Acquired	Developer of molecular diagnostic kits to detect infectious and genetic diseases	-	IMM Investment, Songhyun Investment & 3 others	57/100